ALZpath Strengthens Market Leadership with Abbott Agreement to Help Enable Early Alzheimer’s Diagnosis at Global Scale CARLSBAD, Calif., June 24, 2026 /PRNewswire/ — ALZpath Inc., the leader in blood test-based diagnostic solutions for Alzheimer’s disease, today announced a licensing…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
